[1]
Baratloo, A. et al. 2016. Intravenous caffeine versus intravenous ketorolac for the management of moderate to severe migraine headache. Bangladesh Journal of Pharmacology. 11, 2 (Apr. 2016), 428–432. DOI:https://doi.org/10.3329/bjp.v11i2.26333.